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Abstract
Background: Mainly dependent on hormone-sensitive lipase, lipolysis is differently impaired between fat depots in
human obesity. Perilipin A expression is a critical element in adipocyte lipolysis. The present study aimed at comparing
expression and subcellular distribution of perilipin and hormone-sensitive lipase in two abdominal adipose tissues of lean
and obese women. We examined whether regional differences in perilipin expression contribute to impaired lipolytic
rates.
Methods: Abdominal subcutaneous and omental adipose tissues were obtained from six lean and ten obese women.
We measured total protein content and relative distribution of hormone-sensitive lipase and perilipin proteins between
lipid and non-lipid fractions in tissue homogenates. Hormone-sensitive lipase and perilipin mRNA levels, adipocyte size,
basal (non-stimulated) and noradrenaline-stimulated lipolysis in isolated adipocytes were determined.
Results: Adipocytes were significantly larger in the obese versus the lean women and in subcutaneous versus omental
fat. Expressed as a function of cell number, basal lipolysis and noradrenaline responsiveness were higher in subcutaneous
versus omental adipocytes from the obese women (P < 0.05). Despite higher or identical mRNA levels in the lean and
the obese subjects and in subcutaneous and omental tissues, perilipin protein expression was lower in both depots in
the obese versus the lean women, and in subcutaneous versus omental in both lean and obese women (P < 0.05). Perilipin
was mostly (above 80%) present in the lipid fraction in both depots from the obese patients and the value decreased to
60% in the lean subjects (P < 0.05). Perilipin protein expression was inversely correlated to adipocyte size and basal
lipolysis in both depots. Despite higher mRNA levels, hormone-sensitive lipase protein expression decreased in both
depots of the obese women. Regional difference for hormone-sensitive lipase was reported in lipid fraction of
subcutaneous fat of the obese subjects: hormone-sensitive lipase content was twice as low as in omental adipose tissue.
Conclusion: In both fat depots, a reduced perilipin protein expression was observed in women obesity. Perilipin protein
level may contribute to differences in basal lipolysis and in adipocyte size between fat depots and may regulate lipid
accumulation in adipocytes. Differences in hormone-sensitive lipase subcellular distribution were reported between fat
depots in the obese women.
Published: 18 December 2009
Lipids in Health and Disease 2009, 8:58 doi:10.1186/1476-511X-8-58
Received: 16 October 2009
Accepted: 18 December 2009
This article is available from: http://www.lipidworld.com/content/8/1/58
© 2009 Ray et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Lipids in Health and Disease 2009, 8:58 http://www.lipidworld.com/content/8/1/58
Page 2 of 10
(page number not for citation purposes)
Background
Obesity results from a long term imbalance between stor-
age and mobilization of triacylglycerols (TAGs) in adipose
tissue [1]. It is commonly accepted that the ability to stim-
ulate lipolysis (TAG mobilization) is impaired in obese
adipose tissue [2]. Resistance to catecholamines-induced
lipolysis is demonstrated in abdominal subcutaneous
(SC) fat of obese subjects [3]. A more distal defect in cate-
cholamine signal transduction at the level of hormone-
sensitive lipase (HSL, the rate-limiting enzyme for hydrol-
ysis of stored TAGs) is observed in SC fat of obese women
and is linked to decreased expression and activity of HSL
[4].
It is now apparent that other specific proteins located at
the surface of lipids droplets i.e. the perilipin family have
also an important role in the control of lipolysis. The
spliced isoforms of perilipins A (PLIN) and B are found in
adipocytes, the A form being largely predominant in
mature adipocytes [3]. In the basal state (in the absence of
stimulation of lipolysis), perilipins are mainly present on
the surface of lipid droplets and prevent LHS from TAGs
hydrolysis [5]. When lipolysis is stimulated by β-adrener-
gic agents, perilipins phosphorylation in response to PKA
activation induces an important physical alteration of the
droplet surface that facilitates the action of phosphor-
ylated lipases such as HSL and initiates lipolysis [6-8].
PLIN suppression in mice increases basal lipolysis (rate of
lipolysis under unstimulated conditions) and prevents
the development of obesity induced by a high fat diet [9].
PLIN ablation reverses obesity in db/db mice [10]. Evi-
dence for a role of perilipin in humans is also provided
[11-13]. These studies confirm the presence of perilipin A
in human adipose tissue. Low perilipin content in
abdominal SC adipose tissue is associated with a high
basal lipolytic rate of isolated adipocytes [11,12].
Human adipose tissue displays significant regional differ-
ences in adipocyte size, basal metabolic activities and hor-
monal responsiveness [3]. These differences probably
contribute to regional fat deposition. Regional differences
in regulation of lipolysis were shown in vitro and in vivo
[3,14]. The interpretation of these studies is complex and
generates equivocal data since it depends on gender, fat
depot (intra-abdominal and more peripheral depots),
body mass index (BMI) and the choice of lipolysis units
[3,15-18]. Abdominal adipocytes are generally believed to
be hyperlipolytic by being highly responsive to catecho-
lamine stimulation [17,19]. Most studies using isolated
adipocytes show higher basal lipolysis in SC versus omen-
tal (OM) adipocytes [17,20,21]. Regarding HSL expres-
sion, a decrease is reported in SC depot of obese subjects
versus lean subjects [4]. Despite the crucial role of the adi-
pose tissue heterogeneity, few studies only attempt to
compare expression of HSL and perilipin in different fat
depots. The present report aimed at examining whether
HSL and perilipin A were differently expressed in abdom-
inal SC and OM adipose tissues of women and if these
expressions and regional differences were modified in
obese subjects.
Methods
Subjects
Written informed consent was obtained from 10 obese
and six lean women. All of them had normal physical
examination and none took any medication. The study
was approved by the local ethical committee and the
French National Institute of Health and Medical Research
(INSERM). Samples of abdominal SC and OM adipose tis-
sues were collected at the beginning of surgery in obese
subjects and in three lean subjects under general anesthe-
sia with propofol. The SC adipose tissue biopsies were
obtained by needle aspiration under local anesthesia with
lidocaïne in an additional group of three lean subjects.
Previous data have shown that the adrenergic regulation
of lipolysis is not influenced by the mode of sampling in
SC fat cells. Therefore we decided to pool data generated
from both forms of anesthesia [22]. All samples were col-
lected in the post-absorptive state. They were frozen in liq-
uid nitrogen and stored at -80°C until analysis, except for
a small part of the biopsies that was used for measuring fat
adipocyte volume.
Preparation of isolated fat cells and determination of 
adipocyte volume
Isolated fat cells were prepared with collagenase according
to Rodbell [15]. An aliquot of cells was suspended in an
albumin buffer solution and placed on a glass slide to
determine the diameter of 100 cells with a microscope
(Carl Zeiss, Inc. Thornwood, NY) equipped with a caliper
scale. Mean fat cell volume was calculated according to
the methods developed by Hirsch and Gallian [23].
Lipolysis experiments
Isolated fat cells from adipose tissue biopsies were incu-
bated as described in detail [17]. In brief about 5-10,000
cells per ml isolated by collagenase treatment, were incu-
bated in Krebs-Ringer phosphate (pH 7.4) containing
albumin (20 g/L); glucose (1 g/L) and ascorbic acid (0.1
g/L) in the absence or in the presence of increasing con-
centrations (10-11-10-4 M) of noradrenaline. Two hours
later, the glycerol concentration was determined with a
luminometer method and was used as an index of lipoly-
sis. The non-selective adrenergic agonist noradrenaline
represents the natural catecholamine effect and causes a
concentration dependent stimulation of glycerol release
which reached a plateau at the highest concentrations.
The lipolytic capacity was calculated by dividing the
noradrenaline-induced glycerol release per basal glycerol
release. An index for the sensitivity to noradrenaline is theLipids in Health and Disease 2009, 8:58 http://www.lipidworld.com/content/8/1/58
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pD2 value, the negative logarithm of the EC50 value,
which is the concentration of the agonist giving half of its
maximum effect. This value was determined by linear
regression analysis after log-logit transformation of the
ascending part of the concentration-response curve. Max-
imal lipolytic rate of noradrenaline was used as indica-
tions of responsiveness. The lipolytic rates were also
corrected for the difference in basal lipolysis between adi-
pose tissues by subtracting the basal values. Lipolysis was
expressed per number of cells incubated. Due to limited
weight of biopsies in lean subjects, lipolysis experiment
was only performed in biopsies from obese subjects.
Perilipin and HSL mRNA expression
Total RNA was extracted using the RNeasy total RNA kit
(Qiagen, Courtaboeuf, France). RNA concentration and
purity were determined by measuring optical density at
260 and 280.nm and integrity was verified by agarose gel
electrophoresis. HSL mRNA levels were measured by RT-
competitive PCR as described previously [24,25]. Perili-
pin mRNA levels were measured by RT-PCR using β-actin
as a standard. The primers sequences 5'-CTGAGCAGCCT-
GGCCCAGT-3' and 5'-ATTCGCTCTCGGGCTCCATC-3'
were respectively used as the forward and the reverse
primers for the β-actin gene and 5'-GACGAGGCCCA-
GAGCAAGAGA-3' and 5'-GGGTGTTGAAGGTCT-
CAAACA-3' for the perilipin gene.
Immunoblot analysis
Frozen adipose tissue samples (300 mg) were homoge-
nized with an ultra Turrax apparatus (IKA Werke, Sweden)
in 0.6 ml of lysis buffer (0.25 M sucrose, 1 mM EDTA, 50
mM NaF, 1 mM benzamidine in 50 mM Tris-HCl buffer
pH 7.5), with protease inhibitors (20 μg/ml leupeptin, 20
μg/ml antipain, 1 μg/ml pepstatin) and phosphatase
inhibitors (okadaïc acid, phosphatase inhibitors cocktails
I and II, from Sigma, L'Isle d'Abeau, France). Infranatant I
(fat-free homogenate) and fat cake (FC) were separated by
centrifugation (12,000 g for 20 minutes at 4°C). The fat
cake was washed once more with 0.6 ml of lysis buffer
(I2). Proteins present in the FC fraction were extracted
twice over by centrifugation in 0.6 ml of 125 mM Tris
buffer with 5% SDS, 20% glycerol, proteases and phos-
phatase inhibitors and both fractions were mixed
together. Preliminary experiments showed that additional
extractions of the fat cake proteins and the infranatant
yielded no more proteins (Data not shown). Total protein
contents were measured by BCA assay (Pierce, Rockford,
IL). Aliquots corresponding to 40 μg and 10 μg of total
proteins for I and FC fractions respectively were analyzed
by SDS-PAGE and transferred to PVDF membranes along
with a standard of recombinant human HSL (C. Holm,
Lund, Sweden) used for normalization of the results
between different immunoblots. I and FC extracts of SC
and OM biopsies of a given subject were all analyzed from
the same immunoblot.
Immunoblotting was performed with either an affinity-
purified polyclonal rabbit anti-human HSL antibody
(1:1,000) (C. Holm, Lund, Sweden) or an anti-perilipin
antibody (Progen, Heidelberg, Germany 1:2,000) and the
suitable secondary antibodies, before a brief incubation
with enhanced chemiluminescence detection reagents
(ECL, Amersham, Buckinghamshire, UK). Autoradio-
graphs were quantified by densitometry (Imagemaster
TotalLab, Amersham, Buckhinghamshire, UK) and
expressed according to adipose tissue weight.
HSL enzymatic activity
It was measured on I fractions using the diolein analogue
1(3)-mono [3H] oleoyl-2-oleylglycerol as substrate as
described previously [24,25]. One unit of enzyme activity
is defined as 1 μ mole of oleic acid released per minute at
37°C. Since the phosphorylated and dephosphorylated
forms of the enzyme have the same activity toward diglyc-
eride substrates, the total amount of activable enzyme in
the sample is measured [24,25]. Samples were analyzed in
triplicate and lipase activity was related to the weight of
homogenized adipose tissue. Due to limited amount of
tissue sampled from most lean subjects, HSL activity was
not measured in these subjects.
Statistical analysis
Results are shown as mean and SEM. Statistical analysis
was performed using two-tailed Student's t-test for paired
values (SC versus OM) and Mann-Whitney test (obese ver-
sus controls). P < 0.05 was considered significant. Analy-
sis of trends was performed using linear regression.
Results
Clinical Characteristics of the two groups of subjects
(Table 1). As expected for obese women, plasma triacylg-
lycerols and non-esterified fatty acids were higher than in
the lean women (P < 0.05). Although the obese subjects
had higher plasma insulin and glucose concentrations
than controls, none had overt type 2 diabetes. Adipocyte
volume was highly different between our groups of tis-
sues: adipocytes from obese women are twice and 5-fold
as big as adipocytes from lean women in SC and OM
depot respectively (P < 0.01). In the lean women, the SC
adipocytes volume was 420% bigger than the OM adi-
pocytes (P < 0.05). In the obese women, the volume dif-
ference reached 210% (P < 0.05).
HSL and PLIN mRNA levels
In the obese subjects, HSL mRNA level was higher in SC
than in OM adipose tissue (21.5 ± 4.9 versus. 14.7 ± 2.8
attomoles/μg RNA respectively, P < 0.05). The corre-
sponding values in the lean women were 6.8 ± 0.3 in SC
adipocytes and 4.5 ± 0.3 attomoles/μg RNA in OM adi-
pocytes (p < 0.05). In both depots, HSL mRNA abundance
in the obese women were 300% higher than in the lean
women (p < 0.05). In the obese subjects, PLIN mRNALipids in Health and Disease 2009, 8:58 http://www.lipidworld.com/content/8/1/58
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abundance expressed relative to β-actin was significantly
higher in SC than in OM adipose tissue (1.48 ± 0.24 ver-
sus. 0.75 ± 0.22, P < 0.01). The corresponding values in
the lean subjects were 0.81 ± 0.07 and 0.87 ± 0.25 (P >
0.05). Therefore, values were comparable in OM adipose
tissue for the obese and the lean women, but perilipin
mRNA values in SC adipose tissue were significantly
higher in the obese than in the lean women (P < 0.05).
Intra-cellular content and distribution of HSL and perilipin
The Western blot analysis was performed on frozen adi-
pose tissue. We investigated whether the freezing/thawing
cycle modified the distribution of HSL and perilipin
between fat-free homogenate and fat cake. Additional
immunoblots were performed with freshly collected and
frozen samples of the same tissue from two lean and two
obese (Zucker) rats and from one obese human. Identical
results were obtained (data not shown) and suggested that
freezing/thawing cycle have not damaged the lipid drop-
lets.
Figure 1 shows a representative immunoblot of adipose
tissue from an obese subject. HSL and perilipin A were
detected as bands at 80 kDa and 62 kDa respectively. A
band at 45 kDa was occasionally detected in FC extracts
and probably represented perilipin B. HSL and perilipin A
protein contents (Figures 2 and 3 respectively) were esti-
mated in whole tissue (called "total" fractions), in fat cake
fractions (FC), and in fat-free homogenates (I). The values
were normalized to the weight of adipose tissue used for
homogenization. In both depots, HSL and perilipin
amounts were lower in the obese than in the lean subjects
(P < 0.05), this difference being particularly important for
perilipin. Amounts of total HSL protein were comparable
between fat depots for both lean and obese subjects but
the content in FC fractions of OM tissues was twice as
much as that in FC fractions of SC tissues (P < 0.05) (Fig-
ure 2). Concerning perilipin A (Figure 3), all protein frac-
tions of both depots were lower in the obese than in the
lean women (from a 4 to a 10 fold reduction) (P < 0.05)
Whatever the BMI, the amounts of perilipin A in OM tis-
sue increased by 100 to 200% compared with SC adipose
tissue (P < 0.05) in all fractions (total, FC and I) except in
I fraction of lean subjects where the trend for higher values
was not significant (P = 0.06).
Figure 4 shows the percent cellular distribution of HSL
and perilipin between fat-free homogenates and fat cake
extracts. Perilipin was mostly (more than 80%) present in
the fat-cake fraction in both adipose tissues of the obese
subjects, this predominance in fat cake extracts being less
marked (around 60%) in both depots of the lean women
(P < 0.05 versus the obese). The majority (55 to 65%) of
HSL protein was found in the non-lipid fractions. The
HSL distribution was comparable in the lean and the
obese subjects whatever the fat depot, except in lean and
obese FC fractions which displayed an HSL content in OM
depot twice as high as in SC fat tissue.
HSL activity
Maximal HSL activity was measured in the fat-free
homogenates of SC and OM adipose tissues in obese sub-
Table 1: Characteristics of lean and obese women
Lean subjects
n = 6
Obese subjects
n = 10
Age, years 31.5 ± 5.7 32.1 ± 2.9
BMI, kg/m2 22.6 ± 1.0
(22,5-25,3)
42.0 ± 1.4**
(35,4-50,2)
Pl. Triacylglycerols, mM 1.1 ± 0.2 1.9 ± 0.3*
Pl. NEFA, mM 0.60 ± 0.20 0.99 ± 0.11**
Pl. Cholesterol, mM 4.6 ± 0.3 5.5 ± 0.3
Pl. Glucose, mM 4.4 ± 0.4 5.4 ± 0.1*
Pl. Insulin mU/L 7.0 ± 1.0 16.6 ± 2.9*
Pl. Glucagon, ng/L ND 132 ± 12
SC fat cell volume, pL 590 ± 110 1410 ± 130**
OM Fat cell volume, pL 140 ± 50 $ 670 ± 120** $
Values are given as the mean ± SEM. * p < 0.05, ** p < 0.01 versus 
lean subjects.
$ p < 0.05 versus the corresponding value of subcutaneous tissue in 
the same group of subjects.
ND; not defined Pl.; plasma BMI; body mass index SC; subcutaneous 
adipose tissue OM; omental adipose tissue NEFA; non esterified fatty 
acids pL; picolitre
Representative Western blot analysis of HSL and perilipin in  homogenates from subcutaneous (SC) (lines 1-2-3) and  omental (OM) adipose tissues (lanes 4-5-6) from an obese  woman Figure 1
Representative Western blot analysis of HSL and 
perilipin in homogenates from subcutaneous (SC) 
(lines 1-2-3) and omental (OM) adipose tissues (lanes 
4-5-6) from an obese woman. Lanes 1 and 4 contained 
perilipin and HSL proteins of fat-free infranatants (I1) (40 μg 
of total proteins). Lanes 2 and 5 contained proteins from the 
second fat-free infranatants (I2) (40 μg of total proteins). 
Lanes 3 and 6 contained perilipin and HSL proteins extracted 
from the fat cake (FC) (for more details, see research meth-
ods and procedures).
    SC        OM 
Perilipin A 62kDa
LHS  88 kDa  
1 2 3   4 5 6 Lipids in Health and Disease 2009, 8:58 http://www.lipidworld.com/content/8/1/58
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jects. They were comparable (28.5 ± 0.7 vs. 27.2 ± 1.0 mU/
μg of adipose tissue respectively).
Basal and noradrenaline-stimulated lipolysis in isolated 
adipocytes from obese women
are reported in Figure 5A, and values are expressed per cell
number. Basal lipolysis was 50% lower in OM adipocytes
compared with SC cells (P < 0.01). The maximal and sub-
maximal lipolytic responses to noradrenaline were also
lower in OM adipocytes (P < 0.05). In Figure 5B, the lipo-
lytic rates were corrected for the difference in basal lipoly-
sis between SC and OM fat tissue, by subtracting the basal
values. The only remaining difference between both tis-
sues was a higher sensitivity to noradrenaline of OM adi-
pocytes, as evaluated by the pD2 value (P < 0.05).
Correlation between perilipin protein, adipocyte volume 
(Figure 6A) and basal lipolysis (Figure 6B)
Total perilipin protein content was negatively correlated
to the volume of adipocyte isolated from both depots
from the lean and the obese subjects (R2 = 0.56, P < 0.05).
It was also negatively correlated with basal lipolysis in
both depots from the obese women (R2 = 0.56, P < 0.05).
A similar negative linear correlation was obtained
between the mean fat cells diameter and the perilipin con-
tent in FC fractions (R2= 0.60, P < 0.05) (data not shown).
Discussion
In the present study, regional differences of perilipin A
and HSL expressions were examined in lean and obese
women. The main results were summarized in Table 2.
Depot-specific differences in HSL expression
Despite higher HSL mRNA levels in SC versus OM adipose
tissues, we did not find any regional difference in HSL
protein content in both lean and obese women and in
Quantification of HSL proteins in subcutaneous and omental  adipose tissues of obese (upper graph) and lean women  (lower graph) Figure 2
Quantification of HSL proteins in subcutaneous and 
omental adipose tissues of obese (upper graph) and 
lean women (lower graph). The relative amount was 
measured in pooled fat-free infranatants (I: I1+I2), fat cakes 
(FC) and whole material (Total).* P < 0.05 versus the corre-
sponding value in lean women, $ p < 0.05 versus the corre-
sponding value of subcutaneous tissue in the same group of 
subjects.
*
*
800
600
400
200
0
500
400
300
200
100
0
$ *
*
*
*
Total  FC    I Total  FC    I
OBESE
$
Total  FC    I Total  FC    I
Subcutaneous              Omental
   LEAN
Arbitrary units/mg adipose tissue
Quantification of perilipin proteins in subcutaneous and  omental adipose tissues of obese (upper graph) and lean  women (lower graph) Figure 3
Quantification of perilipin proteins in subcutaneous 
and omental adipose tissues of obese (upper graph) 
and lean women (lower graph). The relative amount was 
measured in pooled fat-free infranatants (I: I1+I2), fat cakes 
(FC) and from whole material (Total).* P < 0.05 versus the 
corresponding value in lean women, $ P < 0.05 versus the 
corresponding value of subcutaneous tissue in the same 
group of subjects.
*
Arbitrary units/mg adipose tissue
100
$ OBESE *
80 $*
60
* * 40
$* 20
*
0
TOTAL  FC     I TOTAL  FC     I
800
LEAN
0
200
400
600
$
$
TOTAL  FC     I TOTAL  FC     I
Subcutaneous           OmentalLipids in Health and Disease 2009, 8:58 http://www.lipidworld.com/content/8/1/58
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HSL activity in the obese women (lean women were not
analyzed for HSL activity). Some differences in HSL gene
expression between fat depots have been previously
reported [21,26,27]. The direction of fat-depot differences
is unclear. HSL mRNA level is either identical in both
depots [26,27] or higher in SC depot than in OM fat [21],
like it was in the present analysis. Our data suggest that
there was no depot-specific difference in HSL protein
expression in our cohort. The absence of correlation
between protein expression and mRNA level suggests that
HSL may be regulated at some post-transcriptional levels
(such as phosphorylation which activates HSL activity and
induces HSL translocation from the cytosol to the lipid
droplet upon adipocyte stimulation [3]).
HSL distribution between FC and non-lipid fractions in
adipocytes showed a higher percentage of HSL coated the
lipid droplet in OM tissue compared to SC fat from the
obese women (Figure 4). We can therefore speculate that
under catecholamine stimulation, 75% of HSL (the I frac-
tion in SC adipocytes from the obese women) could move
to the lipid droplet compared to 50% only in OM cells)
and could be responsible for a higher hydrolysis of TAG in
SC adipocytes versus OM cells. In the lean women, a trend
for a similar mechanism did not reach significance. Depot
difference in the HSL distribution could therefore influ-
ence HSL regulation and modulate TAG accumulation.
We estimated that 55 to 65% of the HSL proteins were
localized in the fat-free homogenates in both depots in
the resting state (figure 4). This is in agreement with the
60% of HSL being associated with lipids under non-stim-
ulated conditions in cultured adipocytes [28]. As reviewed
by M. Lafontant [3], the recent model suggesting that HSL
is diffusively distributed throughout the cytosol in
unstimulated cells and moves from the cytosol to the sur-
face of lipid droplets where it induces lipolysis, is imper-
fect. According to our data, around 60% of HSL proteins
were localized in the non-lipid fraction in the resting state.
Depot-specific differences in perilipin expression and 
lipolysis
The present study reported regional differences in lipoly-
sis regulation. Basal lipolysis and maximal noradrenaline-
stimulated lipolysis expressed per cell number increased
in SC versus OM adipocytes in the obese women. Our
findings concerning a decreased basal lipolysis in OM ver-
sus SC fat depot are consistent with several previous stud-
ies [16,17,20,21,29]. As regards to pD2, an increased
sensibility to noradrenaline in OM fat depot versus SC
adipose tissue suggests that part of the regional differences
in noradrenaline-induced lipolysis was due to site varia-
tions in β1-,2-,3- adrenoceptor subtype and/or the α-2-
adrenoceptor subtype. According to noradrenaline
responsiveness, SC adipocytes which displayed some
higher volumes than OM adipocytes, were more lipolytic
on an absolute basis. It is consistent with the notion that
larger adipocytes accumulate more triglycerides and
release more fatty acids than smaller adipocytes [16,30].
As SC adipocytes are generally larger than those in OM fat
depot [16,17,21,31,32], it suggests that SC adipocytes dis-
played a higher fat storage capacity than OM adipocytes.
A 2-fold increase of perilipin protein level was found in
OM versus SC adipose tissue in both obese and lean
women. Conversely, perilipin mRNA levels were either
increased in SC versus OM fat depot in the obese women
or not statistically different in the lean women. These
results suggest that perilipin may be regulated at post-
transcriptional levels which could include effects on
mRNA stability, transcription efficiency and phosphoryla-
tion. They confirm previous studies [12,33]. Mechanisms
controlling the protein stability of perilipin are largely
Distribution of HSL (lower panel) and perilipin (upper panel)  between fat-free homogenate (I) and fat cake (FC) in subcu- taneous (SC) and omental (OM) adipose tissues of lean and  obese women Figure 4
Distribution of HSL (lower panel) and perilipin 
(upper panel) between fat-free homogenate (I) and 
fat cake (FC) in subcutaneous (SC) and omental 
(OM) adipose tissues of lean and obese women. * P < 
0.05 versus the corresponding value in lean subjects. $ P < 
0.05 versus the corresponding value of subcutaneous tissue 
in the same group of subjects.
% of total amount
0
20
40
60
80
100 HSL
OBESE                  LEAN
SC       OM SC       OM
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unknown in adipocytes. Kovsan et al. proposed that pro-
teolysis of perilipin involving the lysosomial protein deg-
radation machinery may constitute a novel mechanism
for regulating adipocyte lipolysis [34]. Perilipin subcellu-
lar distribution did not show any differences between fat
depots whatever the BMI (figure 4).
Up to date, depot-specific differences in perilipin expres-
sion were only investigated in two studies involving
human [12,33]. Both studies do not find any significant
difference of perilipin content between both fat depots in
obese subjects. The discrepancy between these studies and
our results could reside in gender differences since the
material in previous studies is composed of adipose tis-
sues from males and females [12,33]. Actually Wang et al
[12] found higher perilipin protein content in SC adi-
pocytes from obese men compared with women. We
think therefore that it was more relevant to study perilipin
expression either in men or in women (as it is in the
present study).
Regional differences in basal, noradrenaline-stimulated lipolysis in adipocytes isolated from omental (OM) and subcutaneous  (SC) adipose tissue Figure 5
Regional differences in basal, noradrenaline-stimulated lipolysis in adipocytes isolated from omental (OM) and 
subcutaneous (SC) adipose tissue. Results are expressed as a function of cell number (A) and cell number minus basal 
lipolysis (B) in obese women. Data are mean ± SEM. The lipolytic capacity was calculated by dividing the noradrenaline-induced 
glycerol release per basal glycerol release. An index for the sensitivity to noradrenaline is the pD2 value, the negative logarithm 
of the EC50 value, which is the concentration of the agonist giving half of its maximum effect. Maximal lipolytic rate of 
noradrenaline was used as indications of responsiveness. It was calculated by dividing the noradrenaline-induced glycerol 
release by basal glycerol release. $ P < 0.05 versus the corresponding value of subcutaneous tissue in the same group of sub-
jects $$ P < 0.01 versus the corresponding value of subcutaneous tissue in the same group of subjects.
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The increased perilipin protein expression in OM fat
depot versus SC adipose tissue was negatively correlated
to the mean adipocyte volume (in the lean and the obese
women) and to basal lipolysis in the obese women (Fig-
ure 5). This point will be focused below.
Perilipin and HSL expressions in obese women
In the present study, obesity was associated with a
decreased perilipin and HSL proteins in both adipose tis-
sues. HSL mRNA levels were elevated in both fat depots
whereas perilipin gene expression was either similar or
increased in SC and OM depots respectively. The discrep-
ancy between mRNA and proteins suggests once again
that post-transcriptional regulation of perilipin and HSL
occurred in adipocytes. Due to limited weight of biopsies,
lipolysis experiments were not performed in the lean
women. Therefore the relationship between adipocyte
lipolysis and perilipin expression were not studied. How-
ever, it is commonly accepted that the action of catecho-
lamines is impaired in obesity and that basal rate of
lipolysis is increased in enlarged fat cells of obese subjects
whatever the fat depot [3,4,21]. If perilipin A functions to
restrain basal lipolysis [9], we hypothesized that a
decreased perilipin A protein content contributes to ele-
vated basal lipolysis in large adipocytes of obese women.
Perilipin A expression was only measured in a few studies
involving obese humans [11-13,31]. Most of them found
that the perilipin protein content decreases in SC adipose
tissue of obese patients [11,12] and is associated with a
reduced perilipin mRNA level [12,31]. Only one reported
an increased mRNA and protein contents [13]. The
present data strengthen the findings towards a reduced
perilipin A protein expression in human obesity.
Perilipin proteins were mostly present on the lipid droplet
(80% in obese women and it decreased to 60% in con-
trols). It is consistent with the hypothesis that in the rest-
ing state (non-activated conditions), perilipins coat the
lipid droplet and prevent lipases from TAGs hydrolysis, an
action commonly described as "the barrier function
between lipases and stored neutral lipid" [3]. An
enhanced percentage of perilipin protein was found on
the lipid droplet of obese women whatever the fat depot.
Our results underlined differences in both the perilipin A
protein expression and its subcellular distribution in
Relationship between perilipin proteins in the whole material  (SC and OM adipose tissues of lean and obese women) and  adipocyte volume (upper graph) and basal lipolysis (lower  graph) Figure 6
Relationship between perilipin proteins in the whole 
material (SC and OM adipose tissues of lean and 
obese women) and adipocyte volume (upper graph) 
and basal lipolysis (lower graph). The correlation coeffi-
cient (R2) was calculated using linear regression analysis. (pL; 
picolitre)
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Table 2: Summary of the results obtained in this study between lean and obese subjects and between omental and subcutaneous 
adipose tissues
Perilipin HSL
Ad. tissue mRNA Protein Enzymatic activity mRNA Protein
SC Obese > lean * Obese < lean * ND Obese > lean * Obese < lean *
OM Obese = lean Obese < lean * ND Obese > lean* Obese < lean *
Obese SC > OM * SC < OM * SC = OM SC > OM * SC = OM
Lean SC = OM SC < OM * ND SC > OM * SC = OM
* p < 0.05 ad; adipose ND; not determined Prot; proteins OM; omental SC; subcutaneousLipids in Health and Disease 2009, 8:58 http://www.lipidworld.com/content/8/1/58
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obesity. Up to date no other study investigated perilipin
intracellular distribution in the obese versus the lean sub-
jects. The difference in intra-cellular perilipin A distribu-
tion between lean and obese subjects could be linked to
the higher volume of adipocytes in obese versus lean (and
in SC versus OM fat depot) and hence of lipid droplets, in
obese subjects and (in SC fat depot), offering more sur-
faces for perilipin to anchor. A negative linear correlation
was found between perilipin protein content (Total and
FC fractions) and either the mean adipocyte volume in all
biopsies or basal lipolysis in obese women. These results
suggest that the total content of perilipin, the perilipin
content in FC fractions, and the adipocyte size are strongly
interrelated in SC as well as in OM tissues.
Conclusions
A reduced perilipin protein expression may contribute to
the higher basal lipolytic rate and may contribute to adi-
pocyte enlargement. Regional differences in perilipin
expression between OM and SC adipose tissue metabo-
lism were found in women over the range of body mass
index. Perilipin protein expression may determine lipoly-
tic differences between SC and OM fat depots and may
regulate lipid accumulation in adipocytes. Regional differ-
ence influence HSL distribution in the obese women.
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